S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
NYSE:UHS

Universal Health Services (UHS) Stock Price, News & Analysis

$157.47
+3.82 (+2.49%)
(As of 04:38 PM ET)
Today's Range
$153.66
$157.47
50-Day Range
$153.65
$182.46
52-Week Range
$119.90
$183.61
Volume
902,995 shs
Average Volume
559,180 shs
Market Capitalization
$10.59 billion
P/E Ratio
15.35
Dividend Yield
0.51%
Price Target
$179.71

Universal Health Services MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
14.1% Upside
$179.71 Price Target
Short Interest
Healthy
2.54% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.10
Upright™ Environmental Score
News Sentiment
0.05mentions of Universal Health Services in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$6.19 M Sold Last Quarter
Proj. Earnings Growth
10.34%
From $13.34 to $14.72 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.96 out of 5 stars

Medical Sector

8th out of 911 stocks

General Medical & Surgical Hospitals Industry

1st out of 5 stocks

UHS stock logo

About Universal Health Services Stock (NYSE:UHS)

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. It also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

UHS Stock Price History

UHS Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Wells Fargo Remains a Buy on Universal Health (UHS)
Demystifying Universal Health Servs: Insights From 12 Analyst Reviews
Q4 2023 Universal Health Services Inc Earnings Call
Universal Health Services, Inc. Q4 Profit Increases, beats estimates
See More Headlines
Receive UHS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Universal Health Services and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/27/2024
Ex-Dividend for 3/15 Dividend
2/29/2024
Dividend Payable
3/15/2024
Today
4/19/2024
Next Earnings (Confirmed)
4/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
General medical & surgical hospitals
Sub-Industry
Health Care Facilities
CUSIP
91390310
Employees
96,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$179.71
High Stock Price Target
$203.00
Low Stock Price Target
$152.00
Potential Upside/Downside
+17.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
12 Analysts

Profitability

Net Income
$717.79 million
Pretax Margin
6.58%

Debt

Sales & Book Value

Annual Sales
$14.28 billion
Cash Flow
$18.69 per share
Book Value
$92.24 per share

Miscellaneous

Free Float
56,398,000
Market Cap
$10.33 billion
Optionable
Optionable
Beta
1.24
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

UHS Stock Analysis - Frequently Asked Questions

Should I buy or sell Universal Health Services stock right now?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Universal Health Services in the last year. There are currently 1 sell rating, 4 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" UHS shares.
View UHS analyst ratings
or view top-rated stocks.

What is Universal Health Services' stock price target for 2024?

12 brokerages have issued 1 year price objectives for Universal Health Services' shares. Their UHS share price targets range from $152.00 to $203.00. On average, they anticipate the company's stock price to reach $179.71 in the next year. This suggests a possible upside of 14.1% from the stock's current price.
View analysts price targets for UHS
or view top-rated stocks among Wall Street analysts.

How have UHS shares performed in 2024?

Universal Health Services' stock was trading at $152.44 at the beginning of 2024. Since then, UHS stock has increased by 3.3% and is now trading at $157.47.
View the best growth stocks for 2024 here
.

When is Universal Health Services' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 24th 2024.
View our UHS earnings forecast
.

How can I listen to Universal Health Services' earnings call?

Universal Health Services will be holding an earnings conference call on Thursday, April 25th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Universal Health Services' earnings last quarter?

Universal Health Services, Inc. (NYSE:UHS) posted its quarterly earnings results on Tuesday, February, 27th. The health services provider reported $3.13 EPS for the quarter, beating the consensus estimate of $3.02 by $0.11. The health services provider earned $3.70 billion during the quarter, compared to the consensus estimate of $3.66 billion. Universal Health Services had a net margin of 5.03% and a trailing twelve-month return on equity of 12.08%. The business's revenue for the quarter was up 7.4% on a year-over-year basis. During the same period last year, the firm posted $3.02 EPS.
Read the conference call transcript
.

How often does Universal Health Services pay dividends? What is the dividend yield for Universal Health Services?

Universal Health Services announced a quarterly dividend on Wednesday, January 17th. Shareholders of record on Friday, March 1st will be paid a dividend of $0.20 per share on Friday, March 15th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.51%. The ex-dividend date of this dividend is Thursday, February 29th.
Read our dividend analysis for UHS
.

Is Universal Health Services a good dividend stock?

Universal Health Services (NYSE:UHS) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.50%. The dividend payout ratio is 7.80%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, UHS will have a dividend payout ratio of 5.43% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for UHS.

What guidance has Universal Health Services issued on next quarter's earnings?

Universal Health Services updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of 13.000-14.000 for the period, compared to the consensus EPS estimate of 11.750. The company issued revenue guidance of $15.4 billion-$15.7 billion, compared to the consensus revenue estimate of $15.0 billion.

What is Alan B. Miller's approval rating as Universal Health Services' CEO?

237 employees have rated Universal Health Services Chief Executive Officer Alan B. Miller on Glassdoor.com. Alan B. Miller has an approval rating of 63% among the company's employees. This puts Alan B. Miller in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Universal Health Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Universal Health Services investors own include UnitedHealth Group (UNH), Netflix (NFLX), Broadcom (AVGO), Alibaba Group (BABA), Bank of America (BAC), Walt Disney (DIS), Intel (INTC), Johnson & Johnson (JNJ), NVIDIA (NVDA) and JPMorgan Chase & Co. (JPM).

Who are Universal Health Services' major shareholders?

Universal Health Services' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (0.25%), Los Angeles Capital Management LLC (0.19%), Global Assets Advisory LLC (0.03%), State of Alaska Department of Revenue (0.02%), Olstein Capital Management L.P. (0.02%) and DGS Capital Management LLC (0.01%). Insiders that own company stock include Eileen C Mcdonnell, Eileen C Mcdonnell, Elliot J Md Mba Sussman, Lawrence S Gibbs, Marc D Miller, Marc W Booth, Matthew Jay Peterson, Steve Filton and Warren J Nimetz.
View institutional ownership trends
.

How do I buy shares of Universal Health Services?

Shares of UHS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:UHS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners